Gilberto Marcelo Sperandio da Silva

Author

Also Known As

G. M. Sperandio da Silva, Gilberto Marcelo S da Silva, Gilberto Marcelo S. da Silva, Gilberto Marcelo SPERANDIO DA SILVA, Gilberto Marcelo Sperandio da Silva, Gilberto Marcelo Sperandio-da-Silva, Silva, Gilberto Marcelo Sperandio Da, Silva, Gilberto Marcelo Sperandio da, Sperandio-da-Silva, Gilberto Marcelo

Publications

853

Citations

H-Index

Concepts

All Affiliations

Fundação Oswaldo Cruz Instituto Evandro Chagas Instituto Lauro de Souza Lima Faculdades Oswaldo Cruz Universidade Federal do Rio de Janeiro

About

Gilberto Marcelo Sperandio da Silva is an author at Fundação Oswaldo Cruz specializing in medicine, sepsis, and rehabilitation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	159
2	Health Sciences	1	1	12
3	Applied Physiology	1	1	12
4	Cell Biology	1	1	63
5	Emergency Medicine	1	1	46

Gilberto Marcelo Sperandio da Silva

Publications

596

Citations

H-Index

Page 1

	Year	Citations
Safety of benznidazole use in the treatment of chronic Chagas' disease Alejandro Marcel Hasslocher‐Moreno, Pedro Emmanuel Alvarenga Americano do Brasil, Andréa Silvestre de Sousa, Journal of Antimicrobial Chemotherapy	2012	94
Autophagy Is an Innate Mechanism Associated with Leprosy Polarization Bruno Jorge de Andrade Silva, Mayara Garcia de Mattos Barbosa, Priscila R. Andrade, PLoS Pathogens Autophagy PcrMitophagyMicrobial PathogensImmunodeficienciesImmunology	2017	63
Itraconazole vs. trimethoprim–sulfamethoxazole: A comparative cohort study of 200 patients with paracoccidioidomycosis Sheila Rocha Conceição Borges, Gilberto Marcelo Sperandio da Silva, Mayara da Costa Chambela, Medical Mycology	2014	60
A Clinical Adverse Drug Reaction Prediction Model for Patients with Chagas Disease Treated with Benznidazole Gilberto Marcelo Sperandio da Silva, Mauro Felippe Felix Mediano, Pedro Emmanuel Alvarenga Americano do Brasil, Antimicrobial Agents and Chemotherapy Drug SafetyDrug HypersensitivityAfrican TrypanosomiasisMedicineChagas Disease Treated	2014	50
Functional capacity and rehabilitation strategies in Covid-19 patients: current knowledge and challenges Aline Xavier Frota, Marcelo Carvalho Vieira, Carla Soares, Revista da Sociedade Brasileira de Medicina Tropical Heart FailureFunctional CapacityCovid-19 EpidemiologyRehabilitation StrategiesCovid-19	2021	46
Cardiac rehabilitation program in patients with Chagas heart failure: a single-arm pilot study Mauro Felippe Felix Mediano, Fernanda de Souza Nogueira Sardinha Mendes, Vivian Liane Mattos Pinto, Revista da Sociedade Brasileira de Medicina Tropical	2016	42
Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease Gilberto Marcelo Sperandio da Silva, Mauro Felippe Felix Mediano, Alejandro Marcel Hasslocher‐Moreno, Journal of Antimicrobial Chemotherapy	2017	40
Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial Mayara da Costa Chambela, Mauro Felippe Felix Mediano, Fernanda Martins Carneiro, British Journal of Clinical Pharmacology	2019	25
Progression Rate from the Indeterminate Form to the Cardiac Form in Patients with Chronic Chagas Disease: Twenty-Two-Year Follow-Up in a Brazilian Urban Cohort Alejandro Marcel Hasslocher‐Moreno, Sérgio Salles Xavier, Roberto Magalhães Saraiva, Tropical Medicine and Infectious Disease	2020	25
Selenium Treatment and Chagasic Cardiopathy (STCC): study protocol for a double-blind randomized controlled trial Pedro Emmanuel Alvarenga Americano do Brasil, Andréa Pereira de Souza, Alejandro Marcel Hasslocher‐Moreno, Trials	2014	21

Page 1